Here you can find WACKER's most recent press releases.
As part of its growth strategy for the BIOSOLUTIONS life-science division, WACKER is increasing capacities in the field of biopharmaceuticals for advanced therapies.
Wacker Chemie AG closed Q1 2024 with lower sales and earnings than the strong prior-year quarter.
Christoph Kowitz, currently head of WACKER’s Corporate Research Department, takes charge of the Group’s U.S. subsidiary Wacker Chemical Corporation (WCC) at the beginning of May.
WACKER is all set to present a range of selected silicone products for cosmetics and hair-care applications at this year’s in-cosmetics Global.
WACKER’s mRNA competence center in Halle is to produce an active ingredient based on mRNA and lipid nanoparticles (LNPs) for combating acute respiratory distress syndrome (ARDS).